Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
LAVA Therapeutics NV
| Metric | LAVA Therapeutics NV LVTXHealthcare |
|---|---|
| Quality Score | 57 / 100 |
| Revenue (latest) | $12M |
| Net income (latest) | −$25M |
| Operating margin | −247.8% |
| Net margin | −209.6% |
| Return on equity | −90.5% |
| Return on assets | −31.1% |
| Return on capital (ROCE) | −47.3% |
| Debt / equity | 1.91× |
| Revenue growth (YoY) | 77.0% |
| Altman Z″ (distress) | -4.00 |
| Accruals / assets | −6.9% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.